Login / Signup

Mesenchymal stem cell-based TRAIL delivery inhibits the metastatic state of clinical therapy-resistant progressive neuroblastoma.

Dinesh Babu SomasundaramAndrew MaherSheeja AravindanZhongxin YuBrian M BeschNatarajan Aravindan
Published in: World journal of pediatrics : WJP (2023)
Keyphrases
  • mesenchymal stem cells
  • multiple sclerosis
  • squamous cell carcinoma
  • small cell lung cancer
  • bone marrow
  • umbilical cord